These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1907 related items for PubMed ID: 12543789

  • 1. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
    Thimmaiah KN, Easton J, Huang S, Veverka KA, Germain GS, Harwood FC, Houghton PJ.
    Cancer Res; 2003 Jan 15; 63(2):364-74. PubMed ID: 12543789
    [Abstract] [Full Text] [Related]

  • 2. Protection from rapamycin-induced apoptosis by insulin-like growth factor-I is partially dependent on protein kinase C signaling.
    Thimmaiah KN, Easton JB, Houghton PJ.
    Cancer Res; 2010 Mar 01; 70(5):2000-9. PubMed ID: 20179209
    [Abstract] [Full Text] [Related]

  • 3. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein.
    Mehrhof FB, Müller FU, Bergmann MW, Li P, Wang Y, Schmitz W, Dietz R, von Harsdorf R.
    Circulation; 2001 Oct 23; 104(17):2088-94. PubMed ID: 11673351
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
    Sivaprasad U, Fleming J, Verma PS, Hogan KA, Desury G, Cohick WS.
    Endocrinology; 2004 Sep 23; 145(9):4213-21. PubMed ID: 15192040
    [Abstract] [Full Text] [Related]

  • 5. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C, Rahmani M, Dai Y, Conrad D, Krystal G, Dent P, Grant S.
    Cancer Res; 2003 Apr 15; 63(8):1822-33. PubMed ID: 12702569
    [Abstract] [Full Text] [Related]

  • 6. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells.
    Chaudhary LR, Hruska KA.
    J Cell Biochem; 2001 Mar 26; 81(2):304-11. PubMed ID: 11241670
    [Abstract] [Full Text] [Related]

  • 7. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
    Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
    Kurihara S, Hakuno F, Takahashi S.
    Endocr J; 2000 Dec 15; 47(6):739-51. PubMed ID: 11228049
    [Abstract] [Full Text] [Related]

  • 11. Cell cycle progression and activation of Akt kinase are required for insulin-like growth factor I-mediated suppression of apoptosis in granulosa cells.
    Hu CL, Cowan RG, Harman RM, Quirk SM.
    Mol Endocrinol; 2004 Feb 15; 18(2):326-38. PubMed ID: 14593075
    [Abstract] [Full Text] [Related]

  • 12. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
    Tognon C, Garnett M, Kenward E, Kay R, Morrison K, Sorensen PH.
    Cancer Res; 2001 Dec 15; 61(24):8909-16. PubMed ID: 11751416
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line.
    Sautin YY, Crawford JM, Svetlov SI.
    Am J Physiol Cell Physiol; 2001 Dec 15; 281(6):C2010-9. PubMed ID: 11698260
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Downstream effectors of oncogenic ras in multiple myeloma cells.
    Hu L, Shi Y, Hsu JH, Gera J, Van Ness B, Lichtenstein A.
    Blood; 2003 Apr 15; 101(8):3126-35. PubMed ID: 12515720
    [Abstract] [Full Text] [Related]

  • 16. Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways.
    Campbell M, Allen WE, Sawyer C, Vanhaesebroeck B, Trimble ER.
    Circ Res; 2004 Aug 20; 95(4):380-8. PubMed ID: 15242975
    [Abstract] [Full Text] [Related]

  • 17. Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene.
    Agazie Y, Ischenko I, Hayman M.
    Oncogene; 2002 Jan 24; 21(5):697-707. PubMed ID: 11850798
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O, Cantley LC.
    Exp Cell Res; 2004 Jul 01; 297(1):224-34. PubMed ID: 15194438
    [Abstract] [Full Text] [Related]

  • 19. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
    Guenther MK, Graab U, Fulda S.
    Cancer Lett; 2013 Sep 01; 337(2):200-9. PubMed ID: 23684925
    [Abstract] [Full Text] [Related]

  • 20. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
    Dunn SE, Torres JV, Oh JS, Cykert DM, Barrett JC.
    Cancer Res; 2001 Feb 15; 61(4):1367-74. PubMed ID: 11245436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 96.